- Wide-field Ca2+ imaging in head-fixed adult C57BL/6J mice tracked dorsal cortical activity across propofol anesthesia depth and emergence, with EEG-EMG and behavioral video used to define anesthesia stages.
- The design compared cortical activity and inter-regional functional connectivity between pre-anesthesia wake and post-emergence recovery, and across the propofol stages studied.
- Inter-regional correlation fell after emergence and stayed below pre-anesthesia baseline for at least 1.5 hours, e.g., MO-SS 0.82 ± 0.02 vs 0.67 ± 0.03 (P < 0.05), even as local Ca2+ activity recovered.
- The authors conclude that restoration of large-scale network coordination lags behind return of consciousness, suggesting a dissociation between local activity recovery and network integration.
Pharmacology
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Double-blinded randomized phase I/II trial of 58 participants with radicular pain from lumbosacral spinal stenosis.
- Transforaminal injection of sterile amniotic fluid filtrate was compared with dexamethasone, with safety and pain and function outcomes followed to 6 months.
- At 3 months, more dexamethasone patients had at least 50% pain reduction: back 45.8% vs 15.0% (P=.050) and leg 60.0% vs 25.0% (P=.034).
- Adverse event rates were comparable between groups with no serious intervention-related events, and the trial was stopped early after dexamethasone showed greater benefit.
- Preclinical study of 20 aged mice (18–20 months) with 24-hour EEG recordings, comparing propofol, an intralipid vehicle, and baseline controls.
- Propofol was infused to surgical-level anesthesia, titrated to EEG delta waves, with an equal volume of intralipid as the vehicle comparator.
- Propofol mice had more wakefulness (820 ± 93.3 vs 658 ± 71.1 min; P < .001) and less NREM sleep (539 ± 93.3 vs 699 ± 64.2 min; P < .001) than controls.
- Early after emergence, REM sleep fell (4.31 ± 2.81 vs 23.1 ± 8.26 min; P < .001), and the authors report delayed REM rebound despite satisfied NREM homeostasis.
- A quality improvement project with retrospective pre- and post-intervention data compared PACU narcotic use in pediatric dental patients.
- The intervention combined an intraoperative dexmedetomidine bolus with evidence-based education bundles for PACU nurses and CRNAs.
- Narcotic administration in the PACU decreased significantly after the intervention (p < 0.001), with no reported numeric effect size or confidence interval in the abstract.
- The authors conclude the bundle reduced postoperative narcotic use, with no significant change in length of stay.
- Single-center randomized trial of 98 adults undergoing elective unilateral total knee arthroplasty, with patients, surgeons, and outcome assessors blinded.
- Opioid-sparing anesthesia built on esketamine and dexmedetomidine was compared with conventional opioid-based anesthesia, and both groups had a femoral nerve block and multimodal analgesia.
- At 24 hours, QoR-15 was higher with opioid-sparing anesthesia (118.4 vs 113.3; adjusted difference 5.12, 95% CI 0.51-9.74; P=0.029), and this persisted at 48 hours.
- The authors concluded the strategy improved early QoR-15 scores, but the difference did not reach the minimal clinically important difference; lower PONV, lower CRP, and better 1-month Oxford Knee Score were also reported.
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- Retrospective cohort from the TriNetX US network of adults having major solid tumour surgery from 2014 to 2023, with 29,547 propensity-matched pairs drawn from 176,149 eligible patients.
- Perioperative ketamine on the day of surgery was compared with matched patients who did not receive it.
- Ketamine was not associated with lower 3-year mortality (16.7% vs 16.0%; HR 1.04; 95% CI 1.00-1.09; q=0.187), and 5-year mortality did not differ.
- An exploratory composite of cancer-progression surrogates was lower with ketamine (HR 0.82; 95% CI 0.74-0.92; q=0.013), but the authors conclude there was no mortality benefit.
- Double-blind, placebo-controlled single-center randomized trial of 232 patients aged 60 or older, ASA 1 to 3, undergoing total hip or knee arthroplasty in China.
- Intranasal dexmedetomidine 100 μg versus normal saline given at 21:00 on the night before surgery.
- Delirium within 3 postoperative days occurred in 10.3% versus 20.7% (relative risk 0.50; 95% CI 0.26-0.95; P=0.030) in the intention-to-treat analysis.
- The authors report improved sleep quality and reduced anxiety and pain, with no severe adverse events or nasal mucosal injury, and suggest sleep improvement may partly explain the delirium reduction.
- Systematic review and meta-analysis of 11 randomised trials, including 3904 propofol-based and 3907 volatile-based patients undergoing curative cancer surgery.
- Compared propofol-based with volatile-based anaesthesia for adults having curative cancer surgery, with outcomes pooled using random-effects meta-analysis.
- No significant difference in overall survival (HR 1.05, 95%CI 0.94-1.17, p = 0.42) or recurrence-free survival (HR 1.06, 95%CI 0.95-1.19, p = 0.31).
- Mortality (RR 1.03, 95%CI 0.94-1.13) and recurrence (RR 0.92, 95%CI 0.76-1.12) showed no significant effect, though the authors call recurrence findings inconclusive on trial sequential analysis.
- Anonymous cross-sectional web survey of 874 analyzed responses from pediatric anesthesia members across 43 countries, 83.5% of them European.
- Rocuronium was the most-used agent for routine intubation (68%) and rapid sequence intubation (67%), based on self-reported practice.
- Relaxants were used always or mostly before routine intubation in 47% for neonates and 50% for infants, while 27% always reversed before extubation and only half used quantitative monitoring.
- The authors conclude that practice remains heterogeneous, with children often intubated without relaxants and extubated without consistent reversal, which they flag as a patient safety concern.
- Systematic review and meta-analysis of 15 RCTs including 3,274 older adults undergoing cardiac surgery.
- Perioperative dexmedetomidine was compared with placebo or alternative sedative or analgesic regimens for preventing postoperative delirium.
- Dexmedetomidine lowered postoperative delirium incidence (RR 0.70, 95% CI 0.56 to 0.86, p = 0.001; moderate certainty) but increased reported bradycardia (RR 2.08, 95% CI 1.31 to 3.31).
- The benefit appeared larger against active comparators than placebo or saline. The delirium duration reduction (MD -1.12 days) was low certainty with high heterogeneity.
- Meta-analysis with trial sequential analysis of RCTs in pediatric ENT surgery; ten trials were identified and six (414 patients) were pooled.
- Low-dose propofol given before extubation was compared with placebo for emergence agitation and related outcomes.
- Propofol reduced emergence agitation incidence (RR 0.57, 95% CI 0.42-0.78) and severity (MD -3.94, 95% CI -5.74 to -2.13).
- Time to extubation was slightly longer (MD 1.8 min, 95% CI 1.4-2.3), with no difference in recovery time or PACU length of stay.
- Randomized controlled trial of 92 adults undergoing elective unilateral total hip arthroplasty under spinal anesthesia at a tertiary care operating room.
- Patients received either an ultrasound-guided PENG block or an anterior quadratus lumborum block, each with 30 ml 0.25% ropivacaine plus 4 mg dexamethasone, given 20 minutes before surgery.
- Total 24-hour fentanyl consumption did not differ significantly (237.5 vs 250 μg; p = 0.617), and time to first rescue analgesia was similar (198 vs 241 minutes; p = 0.120).
- The authors found no difference in opioid use, pain scores, or adverse event rates between the two blocks, including intraoperative hemodynamic changes and PONV.
- Systematic review and meta-analysis of 8 randomized trials with 916 children receiving sevoflurane-based general anesthesia, comparing esketamine with placebo.
- Esketamine was compared with placebo for preventing emergence delirium, with no significant differences across dosing, surgery type, route, or timing.
- Emergence delirium was reduced with esketamine (RR 0.35; 95% CI 0.26-0.48; p<0.0001), and postoperative pain scores were lower (SMD -0.58).
- Extubation was modestly prolonged by 1.72 minutes, and nausea and vomiting were reduced (RR 0.69); certainty was moderate for most outcomes, low for extubation time.
- This systematic review and meta-analysis pooled 21 studies (3 randomized trials) with 605 ketamine-treated CRPS patients, mostly at moderate to high risk of bias.
- Pain change was pooled from the earliest post-infusion assessment within 14 days, with scores rescaled to 0-10 against a pooled baseline of 7.4.
- The mean pain change was -3.6 (95% CI -4.7 to -2.5) within 14 days, and longer-term data up to 90 days suggested a gradual return toward baseline.
- Median responder rate was 65% (range 0-100%), but only 3 studies formally assessed predictors; sympathetically maintained pain (aOR 6.54) and obesity (aOR 8.75) had wide CIs.
AI summary not available. Read the source abstract on PubMed.
- This randomised prospective agreement study in 64 children under 5 years compared the precision of kinemyography and electromyography for neuromuscular monitoring.
- Each device was applied to contralateral arms, and precision was measured by the repeatability coefficient of train-of-four ratios at baseline and after sugammadex-assumed recovery.
- Overall repeatability was similar (median difference 0.00, 95% CI -0.01 to 0.01), but kinemyography was less precise below 5 kg (0.08 vs 0.04 at 5 kg or more).
- Train-of-four ratios below 0.9 were more frequent with kinemyography (33% vs 16%, P<0.05). The authors found neither device inferior and report that electromyography stayed precise below recommended limits.
- Single-center retrospective chart review of 524 adults undergoing elective surgery under general anesthesia, comparing sugammadex dosing approaches.
- Sugammadex aliquots (50 mg/0.5 mL) guided by quantitative neuromuscular monitoring were compared with routine full-vial (200 mg) antagonism, with cost modeling of drugs and monitoring.
- Mean gross drug cost was $51.50 per case with aliquots versus $129.05 with full vials; net cost including monitoring was $71.66 versus $149.21.
- Authors conclude aliquoting reduces annual drug acquisition costs and gives consistent savings across dose ranges, with total hospital net savings reported as $20,008.
- In-vitro study spiking serum from 35 premenopausal female volunteers with sugammadex at 15–120 μM, equivalent to clinical doses of 2–19 mg/kg.
- Progesterone was measured by routine electrochemiluminescence immunoassay, and 15 samples were also tested by LC-MS/MS at baseline and at 120 μM.
- Immunoassay progesterone fell about 10% per doubling of sugammadex concentration (F(2,30) = 4.86, p = 0.015), and by a mean of 34.6% (SD 12.4%) at 120 μM versus controls.
- LC-MS/MS detected no statistically significant change, which the authors attribute to immunoassay interference and advise caution when interpreting progesterone results in the presence of sugammadex.
AI summary not available. Read the source abstract on PubMed.
- A prospective multicentre cross-sectional service evaluation across 23 UK NHS hospitals included 233 rapid sequence inductions for emergency intubation outside theatres, excluding 17 cardiac arrest cases.
- Propofol was used in 63% and fentanyl in 74%, with propofol plus fentanyl the most common combination (42%) and a median propofol dose of 1.4 mg/kg.
- Severe hypotension occurred in 24/219 (11%) and severe hypoxia in 14/221 (6%), while post-induction cardiac arrest occurred in 6/233 (3%).
- Of patients without pre-emptive vasopressors, 40/105 (38%) later needed vasopressors, and the authors call for standardised protocols for induction drug choice, dose and vasopressor use.
AI summary not available. Read the source abstract on PubMed.
- Single case report of one 93-year-old man with Parkinson's disease who underwent cemented hemiarthroplasty for a hip fracture, with a Newari-only language barrier.
- Spinal anaesthesia used 3 mL of 0.5% hyperbaric bupivacaine with 5 µg intrathecal dexmedetomidine, chosen to prolong the block after discussion with the orthopaedic team.
- Intraoperative hypotension (three episodes, treated with mephentermine) and hypoglycaemia (55 mg/dL) occurred, followed by transient delirium and aspiration pneumonia; discharged on postoperative day 10.
- The authors conclude spinal anaesthesia was feasible and emphasise dose optimisation, glycaemic monitoring, continuing dopaminergic therapy, delirium prevention, and dysphagia-safe feeding.
- Meta-analysis of 35 randomized trials with 3831 patients comparing intraoperative low-dose IV esketamine (<1 mg/kg) with control for acute postoperative pain.
- Esketamine was compared with control, with outcomes including resting and movement pain, opioid use, rescue analgesia, and adverse events.
- Resting pain was lower at 4 h (MD -1.40, p<0.0001) through 48 h, movement pain at 12 to 48 h, and rescue analgesia was reduced (RR 0.52, p=0.0001).
- Authors describe a modest pain reduction with no significant adverse event difference, but note heterogeneity and limited evidence make the magnitude and consistency uncertain.
AI summary not available. Read the source abstract on PubMed.
- Randomised non-inferiority trial of 455 patients aged 65 or older undergoing lung resection, with delirium assessed by blinded assessors.
- Remimazolam anaesthesia was compared with propofol anaesthesia for postoperative delirium during the first three postoperative days.
- Delirium occurred in 48% versus 31% of patients (RR 1.53, 95% CI 1.21-1.94), with a 16.5% absolute difference (95% CI 7.7-25.3%) that exceeded the 10% margin.
- Emergence delirium was more frequent with remimazolam (46% vs 28%), and the authors concluded remimazolam was not non-inferior to propofol.
- Randomized 2×2 factorial trial in 39 analyzed adults undergoing shoulder surgery in the beach chair position at a single center in London, Canada.
- Compared propofol with sevoflurane maintenance and phenylephrine infusion with ephedrine boluses, using hybrid near-infrared and diffuse correlation spectroscopy over the first 30 minutes.
- Neither anesthetic nor vasopressor affected average rStO2 or rCMRO2, but a time-by-vasopressor interaction (P = 0.004) showed a 9% greater rStO2 decline with phenylephrine.
- Phenylephrine was associated with a 70% rise in relative rCMRO2 over 30 minutes (95% CI, 0.6 to 3.8; P = 0.007), which the authors interpret as progressive desaturation and rising metabolic demand.
- Preclinical study in male and female inbred mice and outbred rats testing a paclitaxel-induced neuropathy protocol, with mechanical, thermal and cold sensitivity measured by von Frey, Hargreaves and cold plate assays.
- Compares a standard commercially available paclitaxel formulation against a clinical formulation used in patients.
- The clinical formulation produced behavioral effects lasting about 3-4 weeks longer than the commercial formulation, with higher plasma drug exposure partly explaining the difference.
- The authors conclude that formulation should be considered when designing neuropathy models and that the findings suggest the value of testing paclitaxel derivatives with milder or shorter neuropathic effects.
- Prospective observational cohort of 547 adults (282 received i.v. methadone, 265 did not) undergoing elective surgery under general anaesthesia.
- Single-dose i.v. methadone at induction was compared with no methadone, typically fentanyl, with QTcF measured before and for 1 h afterward.
- New QTcF >500 ms occurred in 2.5% of methadone patients vs 8.3% of controls (RR 0.34, 95% CI 0.16-0.75, P=0.009).
- The authors concluded a single induction dose of methadone did not prolong QTcF, with no clinically meaningful effect, and dose did not correlate with QTcF change.
- Population PK/PD modelling of 88 paediatric patients aged 0.08 to 15 years undergoing cardiac or thoracic surgery, with induction doses of 0.6 or 0.9 mg/kg ciprofol.
- Opportunistic blood sampling was used, and a two-compartment model with body weight and an empirical maturation term best described ciprofol pharmacokinetics.
- The BIS-concentration relationship was characterised with an effect compartment model only in children under 3 years, and simulations supported weight-stratified maintenance infusions of 1.0 to 1.4 mg/kg/h.
- The authors recommend a 0.6 mg/kg induction dose with weight-based maintenance, while cautioning that extrapolation of PD response to children aged 3 years and older may be inaccurate.
- Randomized parallel-group trial in 36 adults undergoing cardiac surgery with cardiopulmonary bypass at a university hospital.
- Compared a normal remimazolam infusion of 1 mg/kg/h with a low-dose group whose infusion was cut to 0.7 mg/kg/h at bypass initiation.
- Free remimazolam rose over time in the normal-dose group but stayed stable in the low-dose group (time-by-group interaction p = 0.001); the largest adjusted difference was 89 ng/mL (95% CI 58-120) at 30 minutes after bypass termination.
- Free concentrations increased under constant infusion without matching bispectral index changes, and no linear association was found between BIS and drug concentrations.
- Pharmacokinetic study of 20 children aged 1–6 years undergoing general anaesthesia for elective surgery.
- Each child received a single intravenous melatonin bolus of 0.15 mg/kg before the end of surgery, with six plasma samples drawn over 90 minutes.
- Peak concentration (Cmax) was 416,298 pg/mL (IQR 322,230–508,006), elimination half-life 35.2 minutes (SD 8.4), clearance 0.0183 L/min/kg and volume of distribution 0.92 L/kg (SD 0.27).
- The authors concluded these parameters were comparable to adult data, and no emergence delirium occurred; mean maximum FLACC pain score was 1.3 (SD 2.0).
AI summary not available. Read the source abstract on PubMed.
- Retrospective multicentre cohort using a federated health record network, with propensity-matched adults (15,730 total, 7865 per group) undergoing upper GI endoscopy under general anaesthesia after rocuronium.
- Compared reversal of neuromuscular block with sugammadex versus neostigmine, with failure of tracheal extubation (ventilator dependence or reintubation within 30 days) as the primary outcome.
- Extubation failure was 3.88% with sugammadex versus 5.79% with neostigmine (risk ratio 1.49, 95% CI 1.30-1.72, p<0.0001).
- Sugammadex was also associated with less lung atelectasis and unplanned ICU admission, and the authors report similar findings in patients without chronic pulmonary disease.
AI summary not available. Read the source abstract on PubMed.
- Retrospective single-center cohort of 30 critically ill adults with acute or acute-on-chronic liver failure who received MARS and piperacillin-tazobactam, with 121 measurements across 77 sessions.
- Piperacillin concentrations were measured immediately before and after each 8-hour MARS session, and the abstract describes no separate comparator group.
- The mean relative reduction per session was 34% (±7.9%; p < 0.05), with higher creatinine clearance linked to greater drug loss and higher bilirubin to less.
- The authors report that MARS was associated with about a one-third reduction per session and support systematic drug monitoring and individualized dosing, though 31.6% of post-session levels fell below 80 mg/L.
- This study analyzed 311 paired measurements from 29 children aged 6 months to 17 years receiving propofol and fentanyl procedural sedation in a pediatric ICU procedure room.
- It compared the Narcotrend Index (NI), a processed EEG measure, with the Pediatric Sedation State Scale (PSSS) using Spearman rank correlation.
- The correlation was r = 0.61 (95% CI 0.54-0.68; p < 0.0001), and the median NI at the target deep sedation level (PSSS 2) was 39 (IQR 30-50).
- The authors concluded the NI correlates acceptably with the PSSS and may help avoid over- and under-sedation, particularly for less experienced sedation providers.
- Preclinical study in male C57BL6/J mice comparing vincristine alone and the full CVAD regimen, using a newly established CVAD neuropathy model.
- Mice received anakinra, a clinically approved IL-1 receptor antagonist, and the individual CVAD components were tested separately.
- Anakinra prevented vincristine-induced mechanical hypersensitivity and partly reduced CVAD-induced hypersensitivity, without worsening motor function or systemic toxicity.
- Vincristine drove grip strength loss and IL-1-dependent neuroinflammation, while cyclophosphamide and doxorubicin caused sensory hypersensitivity largely independent of IL-1R; dexamethasone did not cause sensory neuropathy.
- This scoping review pooled four pharmacokinetic studies including 174 healthy children aged 1 to 18 years receiving perioperative intravenous lidocaine infusion therapy.
- The included studies used different dosing regimens, such as a 1.5 mg/kg bolus followed by 1 mg/kg/h or 2 mg/kg/h, or 1.5 mg/kg/h infusions, so direct comparison was limited.
- Reported plasma lidocaine levels were detectable and below presumed toxic levels, with the highest mean concentration being 2.82 ± 0.65 μg/mL in one study of 22 children.
- The authors concluded that pediatric pharmacokinetic data are extremely limited and that large multicenter studies are needed to define optimal dosing and dose-response relationships.
- This randomized, patient- and assessor-blinded trial analyzed 109 of 114 enrolled adults undergoing elective laparoscopic or robotic colorectal cancer resection.
- Patients received intravenous lidocaine, intravenous dexmedetomidine, or intrathecal morphine, with plasma MMP-9 at 1 hour postoperatively as the primary outcome.
- MMP-9 was higher with lidocaine than with dexmedetomidine (log-scale difference 0.333; 95% CI 0.0642-0.601; P = .009) and than with intrathecal morphine (0.424; 95% CI 0.0248-0.823; P = .033).
- The authors concluded that the adjuvants had differential effects on biomarkers and immune profiles, and that intrathecal morphine gave superior analgesia; long-term oncologic effects remain unknown.